Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.47 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.46 |
| ▸ | TUBB | P07437 | 1/20 | 0.46 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.46 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.46 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.46 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.46 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.46 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.46 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.46 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.46 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.46 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5167917 | 0.92 | CYP2C19 (0.50) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27545274 | 0.84 | TSHR (0.55) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5517831 | 0.83 | MAPT (0.51) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5515197 | 0.80 | TSHR (0.54) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27480820 | 0.79 | TSHR (0.55) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5648877 | 0.77 | KDM4E (0.46) | CYP2C19TSHRCYP1A2CYP2C9MAPT | |
| SCHEMBL5166992 | 0.77 | KMT2A (0.56) | CYP2C19CYP1A2CYP2C9MAPTLMNA | |
| SCHEMBL30506315 | 0.76 | HSD17B2 (0.76) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL1660365 | 0.76 | HSD17B2 (0.76) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5516179 | 0.72 | CYP1A2 (0.43) | CYP2C19TSHRCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1471058-B1 | PROCESS FOR PRODUCING 1,2,3-TRIAZOLE COMPOUND | MEIJI SEIKA KAISHA (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-20050080270-A1 | Process for producing 1 2 3 triazole compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1471058-A1 | PROCESS FOR PRODUCING 1,2,3-TRIAZOLE COMPOUND | MEIJI SEIKA KAISHA LTD. (JP) | 2004-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080270-A1 | Process for producing 1 2 3 triazole compound | RPS27L, KARS1, STK38L | CYP2C19 30/4885TSHR 718/4885CYP1A2 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.